about
Chronic non-cholestatic liver disease is not associated with an increased fracture rate in children.Matrix-derived serum markers in monitoring liver fibrosis in children with chronic hepatitis B treated with interferon alphaHigh- and low-dose oral delayed-release mesalamine in children with mild-to-moderately active ulcerative colitisConcentrations of gastric mucosal cytokines in children with food allergy and Helicobacter pylori infectionSoluble adhesion molecules ICAM-1, VCAM-1, P-selectin in children with Helicobacter pylori infectionDiagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysisRelative cost-effectiveness of using an extensively hydrolyzed casein formula containing the probiotic Lactobacillus rhamnosus GG in managing infants with cow's milk allergy in Poland.Supplementation with long chain polyunsaturated fatty acids in treatment of atopic dermatitis in children.Probiotic-induced apoptosis and its potential relevance to mucosal inflammation of gastrointestinal tract.Assessment of risk factors for osteoporosis and fractures in children with meningomyelocele.Comparison of phalangeal ultrasound and dual energy X-ray absorptiometry in healthy male and female adolescents.Longitudinal observation of children with enhanced total serum IgE.Transport of micro-opioid receptor agonists and antagonist peptides across Caco-2 monolayer.Helicobacter pylori seroprevalence in children with sleep-disordered breathing.EGFR and Bcl-2 in gastric mucosa of children infected with Helicobacter pylori.Hepatotoxicity caused by montelukast in a paediatric patient.Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.Health-related quality of life in Polish adolescents with Hymenoptera venom allergy treated with venom immunotherapy.Inflammatory changes of the gastric mucosa and serum concentration of chosen growth factors in children.β-casomorphin-7 alters μ-opioid receptor and dipeptidyl peptidase IV genes expression in children with atopic dermatitis.The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE).Correlations of new markers of bone formation and resorption in kidney transplant recipients.Serum laminin-2 and hyaluronan predict severe liver fibrosis in children with chronic hepatitis B.Obstructive hypopnea and gastroesophageal reflux as factors associated with residual obstructive sleep apnea syndrome.The natural history of cow's milk allergy in north-eastern Poland.A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B.Respiratory response to proton pump inhibitor treatment in children with obstructive sleep apnea syndrome and gastroesophageal reflux disease.Sleep-wake schedules in preschool children who snore.Activity of mitogen-activated protein kinases in the esophageal epithelium of patients with Barrett's esophagus.Serum gastrin concentrations in children with primary gastroesophageal reflux and gastroesophageal reflux secondary to cow's milk allergy.Tumor necrosis factor alpha and its soluble receptors in obese children with NAFLD.Thigh circumference as a useful predictor of body fat in adolescent girls with anorexia nervosa.Acid gastroesophageal reflux and intensity of symptoms in children with gastroesophageal reflux disease. Comparison of primary gastroesophageal reflux and gastroesophageal reflux secondary to food allergy.Transient reference values for impulse oscillometry for children aged 3-18 years.The diagnosis and management of food allergies. Position paper of the Food Allergy Section the Polish Society of Allergology.5th Belarusian-Polish Conference: Dermatology and Allergology Without Borders. Grodno, 3-5 May 2017.Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergyICAM-1 expression on conjunctival epithelial cells in patients with cystic fibrosisDental malocclusion is associated with reduced systemic bone mineral density in adolescentsSerum fibrosis markers as predictors of an antifibrotic effect of interferon alfa in children with chronic hepatitis B
P50
Q33691692-8F98FB01-FF70-44F4-A3F3-7F19D9560642Q33867947-B2954254-2CD8-4476-9A78-697230F25B2DQ34631685-C371A634-0D63-4AF9-955D-A00042267484Q36496611-8CECD892-6CBB-4267-A4E7-F66A416B3C8FQ36496623-08BCAA65-EB53-450F-A657-972B64E3FC17Q36496783-2F8B3A92-1174-4D97-91F3-ED83C7723F53Q37069193-8EC8BA23-4669-4E08-9817-E33D3DD1C817Q37327142-BD66D0E9-3EC1-49D4-805C-EFEC59C79C12Q38042545-5803CC0E-363B-46A2-AB17-66C9B52E7EACQ38490997-87CCB1BE-801A-4AAD-9C53-DEE7306B897BQ38511911-27754EDC-E02F-4D72-890E-7FAE00E511DCQ39193019-4D42EB3D-49F8-49B6-85A2-BA8C22107031Q40000119-D3A9F342-64C9-403F-8E0D-A9ABD9FB29CFQ40628473-F4527D92-C8CF-4520-B8CF-540FB7040846Q40698189-212085D5-51A8-4A46-BC83-C8D1FA5750DBQ42098841-BCDE7C2F-A8E4-4D98-8E20-FB3567E6ED48Q42220407-B37DFAD7-7F5C-438C-BE7F-416AB4CA5189Q42686774-4130FCD9-F341-4A83-B271-FAAE47437290Q43108168-555C7D68-11C8-4851-BEAA-2845D4F0FB54Q44347470-9B54A98E-796D-4B4A-8745-6F44AF6DAA53Q44349538-91F36C60-6DE2-44BB-9154-05C73E227D00Q44491065-7A72C493-1E22-44A1-9D9D-A255E124B84BQ44785893-B42BC66A-C4F7-470A-A744-8149D332B9E6Q45037743-E2DE7A1D-F7C0-4171-9B72-FB2756BB2DACQ45756587-B965F6A4-8C56-4102-B825-431D9304DD60Q46509138-964131F3-34CA-49CC-95D9-063028691756Q48237350-FCB23DCC-CFF0-4538-AC64-E3C05EAFF2F6Q48381805-9D983EDA-7679-49A9-8BB0-751A5C26D623Q50426816-EB089E9C-7B1B-402C-8286-3A5B84D3DAACQ51364881-EF878396-358A-4627-80F5-56FE853B60F0Q51403251-9690E7CB-16BB-4F59-81C4-E54FADBA6F72Q51441373-9EC386B3-FCDB-4BE7-AEB1-0256E3A5EA78Q51859607-03E20FD6-5169-44C9-B0C4-54DC9C70917AQ51864335-2020F853-DD01-433A-91A5-A76C70410407Q54261773-91AF82FB-3CC4-4631-BA63-7F1FE4A51567Q55005031-8E852915-1B4A-4FE7-B8F3-5E58559B6E41Q79493124-C74B9A9C-8BE0-47BB-8D56-C39FDF1F3812Q79844472-6EE0F241-3A3C-4A3C-A6E7-1CD22131D2C9Q80279088-79D5A458-E9BD-4E3E-99AE-145D64D263E3Q80345857-B7F66D43-A602-4C38-ABA4-C3AFBB7AAD66
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-7883-6436
@en
name
Maciej Kaczmarski
@ast
Maciej Kaczmarski
@en
Maciej Kaczmarski
@es
Maciej Kaczmarski
@nl
type
label
Maciej Kaczmarski
@ast
Maciej Kaczmarski
@en
Maciej Kaczmarski
@es
Maciej Kaczmarski
@nl
altLabel
Maciej G Kaczmarski
@en
prefLabel
Maciej Kaczmarski
@ast
Maciej Kaczmarski
@en
Maciej Kaczmarski
@es
Maciej Kaczmarski
@nl
P106
P1153
35466959400
P31
P496
0000-0002-7883-6436